Dr Alisa Molotova - Investment Associate (Life Sciences)
Alisa is an Investment Associate in the Seed Funds team with a focus on spin-outs within the life sciences.
Prior to working at Cambridge Enterprise, Alisa lead the commercial strategy at a London-based start-up that had built a platform trusted by scientists at 900+ universities. She was also an executive for Global Biotech Revolution, a non-profit organisation with the primary mission to inspire and support the next generation of professionals in biotechnology. Alisa’s experience extends to working in biopharm innovation R&D and corporate innovation at leading pharmaceutical companies.
Alisa has recently completed a Wellcome Trust PhD programme in Stem Cell Biology & Medicine at the University of Cambridge and has graduated top of the class with MSci in Genetics at the University of Glasgow.
Alisa joined Cambridge Enterprise in September 2019.